Ajanta Pharma Share Price

Ajanta Pharma Limited is an India-based specialty pharmaceutical company. It provides a comprehensive range of specialty branded generic products targeting a broad range of chronic and acute therapies. It is focused on branded generic businesses across India, Asia, and Africa. It has a wide range of therapeutic segments, such as cardiology, anti-diabetes, ophthalmology, dermatology, antibiotic, anti-malarial, pain, respiratory, gynecology, pediatric and general health products. Its business also consists of two verticals: the United States generics and the institutional business in Africa. Its ophthalmology products include Bimat (anti glaucoma), Nepaflam (anti-inflammatory), Softdrops (lubricant), and Olopat (anti-allergic). Its cardiology products include MET XL, Atorfit CV, Antihypertensive Cinod, Rosutor Gold, Dapalex and Vilatin. Its subsidiaries include Ajanta Pharma (Mauritius) Limited, Ajanta Pharma USA Inc., Ajanta Pharma Philippines Inc., and Ajanta Pharma Nigeria Limited.As of 25 May 2026, Ajanta Pharma share price is ₹3,081.50. The stock opened at ₹3,119.80, compared to its previous close of ₹3,107.50. During today's trading session, Ajanta Pharma share price moved in the range of ₹3,070.00 to ₹3,137.30, with an average price of ₹3,103.65 for the day. Looking at its last 52-week, the stock has touched a low of ₹3,070.00 and a high of ₹3,137.30. On the performance front, Ajanta Pharma share price has increased by 22.81% over the last six months and is up 19.67% on a year-on-year basis.

The market capitalization of Ajanta Pharma is ₹38,804 Crs, with a P/E ratio of 36.8 and a dividend yield of 0.00%.